Classification and subtypes of vascular dementia

International Psychogeriatrics

Volumn 15, Issue SUPPL. 1, 2003, Pages 27-37

  Wallin, Anders ^a   Milos, Veronica ^a   Sjögren, Magnus ^a   Pantoni, Leonardo ^c   Erkinjuntti, Timo ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF FLORENCE   (Italy)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Mixed dementia; Poststroke dementia; Subcortical vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEMENTIA; DISEASE CLASSIFICATION; HUMAN; MULTIINFARCT DEMENTIA; NEURORADIOLOGY; STROKE;

EID: 0141819898     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1041610203008937     Document Type: Conference Paper

References (48)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Aral, H., Terajima, M., Miura, M., et al. (1995). Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease. Annals of Neurology, 38, 649-652.
3. Babikian, V., & Ropper, A. H. (1987). Binswanger's disease: A review. Stroke, 18, 2-12.
4. Brun, A. (1994). Pathology and pathophysiology of cerebrovascular dementia: Pure subgroups of obstructive and hypoperfusive etiology. Dementia, 5, 145-147.
5. Chui, H. C., Victoroff, J. I., Margolin, D., et al. (1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology, 42, 473-480.
6. Coffey, C. E., Figiel, G. S., Djang, W. T., et al. (1989). White matter hyperintensity on magnetic resonance imaging: Clinical and neuroanatomic correlates in the depressed elderly. Journal of Neuropsychiatry and Clinical Neuroscience, 1, 135-144.
7. Cummings, J. L. (1994). Vascular subcortical dementias: Clinical aspects. Dementia, 5, 177-180.
8. De Reuck, J., Decoo, D., Hasenbroekx, M. C., et al. (1999). Acetazolamide vasoreactivity in vascular dementia: A positron emission tomographic study. European Neurology, 41, 31-36.
9. Erkinjuntti, T. (1987). Types of multi-infarct dementia. Acta Neurologica Scandinavica, 75, 391-399.
10. Erkinjuntti, T. (1997). Vascular dementia: Challenge of clinical diagnosis. International Psychogeriatrics, 9(Suppl. 1), 51-58.
11. Erkinjuntti, T., Inzitari, D., Pantoni, L., et al. (2000a). Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials: Is a focus on subcortical vascular dementia a solution? Annals of the New York Academy of Sciences, 903, 262-272.
12. Erkinjuntti, T., Inzitari, D., Pantoni, L., et al. (2000b). Research criteria for subcortical vascular dementia in clinical trials. Journal of Neural Transmission, 59(Suppl. 2), 23-30.
13. Erkinjuntti, T., & Pantoni, L. (2000). Subcortical vascular dementia. In S. Gauthier & J. L. Cummings (Eds.), Alzheimer's disease and related disorders annuals (pp. 101-133). London: Martin Dunitz.
14. Fredman, P., Wallin, A., Blennow, K., et al. (1992). Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurologica Scandinavica, 85, 103-106.
15. Gold, G., Giannakopoulos, P., Montes-Paixao, J. C., et al. (1997). Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology, 49, 690-694.
16. Hachinski, V. (1992). Preventable senility: A call for action against the vascular dementias. Lancet, 340, 645-648.
17. Hebert, R., & Brayne, C. (1995). Epidemiology of vascular dementia. Neuroepidemiology, 4, 240-257.
18. Inzitari, D., Erkinjuntti, T., Wallin, A., et al. (2000). Subcortical vascular dementia as specific target for clinical trials. Annals of the New York Academy of Sciences, 903, 510-521.
19. Jagust, W. (1998). Neuroimaging of dementing disorders. In W. R. Merkesbery (Ed.), Neuropathology of dementing disorders (pp. 25-55). New York: Arnold.
20. Konno, S., Meyer, J. S., Terayama, Y., et al. (1997). Classification, diagnosis and treatment of vascular dementia. Drugs and Aging, 11, 361-373.
21. Leys, D., Erkinjuntti, T., Desmond, D. W., et al. (1999). Vascular dementia: The role of cerebral infarcts. Alzheimer Disease and Associated Disorders, 13(Suppl. 3), S38-S48.
22. Lopez, O. L., Larumbe, M. R., Becker, J. T., et al. (1994). Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology, 44, 1240-1245.
23. Mayeux, R., Saunders, A. M., Shea, S., et al. (1998). Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease: Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. New England Journal of Medicine, 338, 506-511.
24. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology, 38, 643-648.
25. Pantoni, L., Garcia, J. H., & Brown, G. G. (1996). Vascular pathology in three cases of progressive cognitive deterioration. Journal of the Neurological Sciences, 135, 131-139.
26. Pantoni, L., Inzitari, D., Pracucci, G., et al. (1993). Cerebrospinal fluid proteins in patients with leucoaraiosis: Possible abnormalities in blood-brain barrier function. Journal of the Neurological Sciences, 115, 125-131.
27. Rocca, W. A., Hofman, A., Brayne, C., et al. (1991). The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. Annals of Neurology, 30, 817-824.
28. Rockwood, K., Ebly, E., Hachinski, V. C., et al. (1997). Presence and treatment of vascular risk factors in vascular cognitive impairment. Archives of Neurology, 54, 33-39.
29. Rockwood, K., Macknight, C., Wentzel, C., et al. (2000). The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Annals of the New York Academy of Sciences, 903, 522-528.
30. Román, G. C., Tatemichi, T. K., Erkinjuntti, T., et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group. Neurology, 43, 250-260.
31. Sabri, O., Ringelstein, E. B., Hellwig, D., et al. (1999). Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke, 30, 556-566.
32. Sjögren, M., Gustafson, L., Wikkelsö, C., et al. (2000a). Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior RCBF-SPET ratio. Dementia and Geriatric Cognitive Disorders, 11, 275-285.
33. Sjögren, M., Minthon, L., Davidsson, P., et al. (2000b). CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. Journal of Neural Transmission, 107, 563-579.
34. Skoog, I., Wallin, A., Fredman, P., et al. (1998). Blood-brain barrier functioning in relation to Alzheimer's disease and vascular dementia: A population-based study on 85-year-olds. Neurology, 50, 966-971.
35. Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997). Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. Journal of the American Medical Association, 277, 813-817.
36. Stewart, R. (1998). Cardiovascular factors in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 143-147.
37. Sulkava, R., & Erkinjuntti, T. (1987). Vascular dementia due to cardiac arrhythmias and systemic hypotension. Acta Neurologica Scandinavica, 76, 123-128.
38. Tullberg, M., Mansson, J. E., Fredman, P., et al. (2000). CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. Journal of Neurology, Neurosurgery, and Psychiatry, 69, 74-81.
39. Verhey, F. R., Lodder, J., Rozendaal, N., et al. (1996). Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology, 15, 166-172.
40. Wahlund, L.-O. (1994). Brain imaging and vascular dementia. Dementia, 5, 193-196.
41. Wallin, A., & Blennow, K. (1994). The clinical diagnosis of vascular dementia. Dementia, 5, 181-184.
42. Wallin, A., Blennow, K., Fredman, P., et al. (1990). Blood brain barrier function in vascular dementia. Acta Neurologica Scandinavica, 81, 318-322.
43. Wallin, A., Blennow, K., & Gottfries, C. G. (1991). Subcortical symptoms predominate in vascular dementia. International Journal of Geriatric Psychiatry, 6, 137-146.
44. Wallin, A., Brun, A., & Gustafson, L. (Compilers). (1994). Swedish consensus on dementia diseases. Acta Neurologica Scandinavica, 157(Suppl.), 1-31.
45. Wallin, A., Edman, Å., Blennow, K., et al. (1996). Stepwise comparative status analysis (STEP): A tool for identification of regional brain syndromes in dementia. Journal of Geriatric Psychiatry, 9, 185-199.
46. Wallin, A., & Sjögren, M. (2001). Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia. Mechanisms of Ageing and Development, 122, 1937-1949.
47. Wallin, A., Sjögren, M., Edman, Å., et al. (2000). Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. European Neurology, 44, 229-235.
48. World Health Organization. (1993). ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva: Author.